MedPath

University Hospital of Montpellier

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website

Routine Health Care of Patients With FSHD

Not Applicable
Completed
Conditions
Primary Disease Fascioscapulohumeral Dystrophy (FSHD)
Interventions
Other: Followed with an initial assessment, six months and followed annually for 3 years corresponding to the usual follow-up of the patient.
First Posted Date
2015-12-04
Last Posted Date
2025-02-21
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
189
Registration Number
NCT02622438
Locations
🇫🇷

Montpellier University Hospital- Saint Eloi Hospital, Montpellier, Languedoc-Roussillon, France

Role of Ultrasound for Evaluating Rheumatoid Arthritis in Remission

Not Applicable
Completed
Conditions
Rheumatoid Arthritis in Remission
Interventions
Other: Articular ultrasound
First Posted Date
2015-12-02
Last Posted Date
2018-06-11
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
116
Registration Number
NCT02618954
Locations
🇫🇷

Montpellier University Hospital, Montpellier, Herault, France

Effects of the Bilateral Mandibular Nerve Block (V3) in Mandibular Osteotomy

Phase 3
Completed
Conditions
Orthognathic Surgery
Maxillofacial Osteotomy
Mandibular Fracture Trauma
Interventions
Procedure: Realization of the V3 block in maxillofacial surgeries
First Posted Date
2015-12-02
Last Posted Date
2022-04-14
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
108
Registration Number
NCT02618993
Locations
🇫🇷

Hôpital Gui de Chauliac, Montpellier, France

Characterization of Breg Cells

Not Applicable
Completed
Conditions
Healthy Volunteers
Arthritis, Rheumatoid
Interventions
Other: blood sampling
First Posted Date
2015-11-26
Last Posted Date
2021-12-29
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
100
Registration Number
NCT02615951
Locations
🇫🇷

Regional University Hospital, Montpellier, Hérault, France

Descriptive Study of Mental Activity

Not Applicable
Completed
Conditions
Psychiatric Disorder Requiring Hospitalization
Interventions
Other: Psychiatry Consultation
First Posted Date
2015-11-26
Last Posted Date
2017-04-07
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
564
Registration Number
NCT02615925
Locations
🇫🇷

CH de MAYOTTE, Montpellier, Mamoudzou, France

Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy

Not Applicable
Completed
Conditions
HIV-1 Infection
Interventions
Biological: HIV DNA
First Posted Date
2015-11-23
Last Posted Date
2021-07-07
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
120
Registration Number
NCT02611895
Locations
🇫🇷

University hospital Montpellier, Montpellier, France

Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide

Phase 3
Completed
Conditions
Termination of Pregnancy
Feticide
Interventions
First Posted Date
2015-11-05
Last Posted Date
2020-12-30
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
66
Registration Number
NCT02597699
Locations
🇫🇷

Hôpital Arnaud de Villeneuve, Montpellier, France

🇫🇷

Nîmes University Hospital, Nimes, France

REFIT Hearing: Remote Fitting of Hearing Aids

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: Remote fitting
Device: Face to face fitting
First Posted Date
2015-10-28
Last Posted Date
2018-05-21
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
60
Registration Number
NCT02589561
Locations
🇫🇷

Hôpital Gui de Chauliac - Service ORL, Montpellier, France

Study by Magnetic Resonance Imaging in the Progressive Forms of Multiple Sclerosis

Not Applicable
Terminated
Conditions
Progressive Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Interventions
Other: Neuropsychological assessment
Other: Neurologic consultation
Other: MRIs (with vasoreactivity testing)
First Posted Date
2015-10-20
Last Posted Date
2021-05-18
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
70
Registration Number
NCT02580669
Locations
🇫🇷

Hopital Gui de Chauliac -Service de Neurologie, Montpellier, France

Impact of Denosumab in the Prevention of Bone Loss in Non-menopausal Women With Anorexia Nervosa

Phase 3
Terminated
Conditions
Anorexia Nervosa
Interventions
Drug: Placebo subcutaneous injections
First Posted Date
2015-10-02
Last Posted Date
2019-01-07
Lead Sponsor
University Hospital, Montpellier
Target Recruit Count
2
Registration Number
NCT02567279
Locations
🇫🇷

CHU Montpellier, Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath